This site is intended for Healthcare professionals only.
×

Aurobindo Pharma gets USFDA nod for Levofloxacin injection


Aurobindo Pharma gets USFDA nod for Levofloxacin injection

New Delhi: Aurobindo Pharma said it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Levofloxacin injection, an anti-infective used in the treatment of bacterial infection in adults. The approval is for Levofloxacin in 5 per cent Dextrose injection in the strengths of 250 mg/50 ml, 500 mg/100 ml, and 750 mg/150 ml, single use containers, Aurobindo Pharma said in a BSE filing. The product is expected to be launched in the first quarter of 2016-17, it added. The approved product is bio-equivalent

Read the full article now

Please Login
Source: PTI
0 comment(s) on Aurobindo Pharma gets USFDA nod for Levofloxacin injection

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted